SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-052250
Filing Date
2021-10-12
Accepted
2021-10-12 07:25:40
Documents
45
Period of Report
2021-10-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea148683-8k_protara.htm   iXBRL 8-K 37487
2 PRESS RELEASE DATED OCTOBER 12, 2021, ISSUED BY THE REGISTRANT ea148683ex99-1_protaratherap.htm EX-99.1 15833
3 PROTARA THERAPEUTICS, INC. CORPORATE PRESENTATION, OCTOBER 2021 ea148683ex99-2_protaratherap.htm EX-99.2 42689
7 GRAPHIC ex99-2_001.jpg GRAPHIC 85841
8 GRAPHIC ex99-2_002.jpg GRAPHIC 184627
9 GRAPHIC ex99-2_003.jpg GRAPHIC 154675
10 GRAPHIC ex99-2_004.jpg GRAPHIC 110080
11 GRAPHIC ex99-2_005.jpg GRAPHIC 94595
12 GRAPHIC ex99-2_006.jpg GRAPHIC 166892
13 GRAPHIC ex99-2_007.jpg GRAPHIC 146668
14 GRAPHIC ex99-2_008.jpg GRAPHIC 120561
15 GRAPHIC ex99-2_009.jpg GRAPHIC 92898
16 GRAPHIC ex99-2_010.jpg GRAPHIC 128304
17 GRAPHIC ex99-2_011.jpg GRAPHIC 104349
18 GRAPHIC ex99-2_012.jpg GRAPHIC 120886
19 GRAPHIC ex99-2_013.jpg GRAPHIC 109436
20 GRAPHIC ex99-2_014.jpg GRAPHIC 140294
21 GRAPHIC ex99-2_015.jpg GRAPHIC 90396
22 GRAPHIC ex99-2_016.jpg GRAPHIC 120762
23 GRAPHIC ex99-2_017.jpg GRAPHIC 125704
24 GRAPHIC ex99-2_018.jpg GRAPHIC 94842
25 GRAPHIC ex99-2_019.jpg GRAPHIC 157562
26 GRAPHIC ex99-2_020.jpg GRAPHIC 173932
27 GRAPHIC ex99-2_021.jpg GRAPHIC 106403
28 GRAPHIC ex99-2_022.jpg GRAPHIC 85477
29 GRAPHIC ex99-2_023.jpg GRAPHIC 128782
30 GRAPHIC ex99-2_024.jpg GRAPHIC 85841
31 GRAPHIC ex99-2_025.jpg GRAPHIC 81139
32 GRAPHIC ex99-2_026.jpg GRAPHIC 100351
33 GRAPHIC ex99-2_027.jpg GRAPHIC 160747
34 GRAPHIC ex99-2_028.jpg GRAPHIC 153022
35 GRAPHIC ex99-2_029.jpg GRAPHIC 106576
36 GRAPHIC ex99-2_030.jpg GRAPHIC 101004
37 GRAPHIC ex99-2_031.jpg GRAPHIC 131088
  Complete submission text file 0001213900-21-052250.txt   5473192

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE tara-20211012.xsd EX-101.SCH 3028
5 XBRL LABEL FILE tara-20211012_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE tara-20211012_pre.xml EX-101.PRE 22361
38 EXTRACTED XBRL INSTANCE DOCUMENT ea148683-8k_protara_htm.xml XML 3669
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 211316891
SIC: 2836 Biological Products, (No Diagnostic Substances)